Trials / Completed
CompletedNCT05625672
EFFICIENCY OF HEMOVIGILANCE MODULE TRAININGS GIVEN TO NURSES
EVALUATION OF THE EFFICIENCY OF HEMOVIGILANCE MODULE TRAININGS
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 125 (actual)
- Sponsor
- Ankara Yildirim Beyazıt University · Academic / Other
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Accepted
Summary
The aim of the present study is to determine the effectiveness of hemovigilance module training given to nurses.
Detailed description
125 nurses from the clinic and intensive care units, who received the most intensive blood transfusion from two different hospitals, were included in the study as the intervention and control groups. The control group was not trained. Only the pretest was administered one week after the posttest. After the pre-test was applied to the nurses in the intervention group, five modules of training, which lasted four hours, were given using interactive methods. Five modules of training were prepared by the researcher. These five modules are the 1st module of training; definition of hemovigilance, its aims, the development of hemovigilance in the world and in Turkey, and legal legislation, Module 2; Donor selection, Blood donation Process, Phlebotomy and Donor reactions, Module 3; blood, blood transfusion, its purpose, properties of blood and blood components, Blood transfusion process, Module 4; acute and delayed transfusion reactions and management, Module 5; It consists of the national hemovigilance system, the organization of the hemovigilance system at the hospital level, Traceability, Trace-back from the Patient to the Donor, and Look-back from the Donor to the Patient. the training was over, the final test was administered. One month later, this test was repeated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Training | Hemovigilance module training |
Timeline
- Start date
- 2022-04-25
- Primary completion
- 2022-05-26
- Completion
- 2022-07-08
- First posted
- 2022-11-23
- Last updated
- 2022-11-23
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT05625672. Inclusion in this directory is not an endorsement.